GlassScriptPhysician profile
John Peter Kmetz
NPI 1902843352
$1,453.06
in general payments reported to CMS, 2019-2025
15 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $201 · 2023: $370 · 2024: $353 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $297.11 | 2023 | Intracept |
| Medtronic, INC. | $174.88 | 2022 | |
| Curonix LLC | $140.47 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $138.78 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Medical Device Business Services, INC. | $124.92 | 2024 | Vistaseal |
| Pacira Pharmaceuticals Incorporated | $122.65 | 2025 | Exparel |
| Pacira Therapeutics, INC. | $83.53 | 2021 | |
| Ferring Pharmaceuticals INC. | $46.99 | 2021 | |
| Si-Bone, INC. | $46.83 | 2021-2022 | |
| Vertos Medical, INC. | $44.57 | 2023 | Mild Device Kit |
| Avanos Medical | $44.28 | 2023-2024 | Trivisc Sodium Hyaluronate |
| Zimmer Biomet Holdings, INC. | $26.90 | 2024 | Mymobility Platform |
| Spr Therapeutics, INC | $24.76 | 2024 | Sprint Pns System |
| Fidia Pharma USA INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kmetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.